ABSTRACT
INTRODUCTION
Pre-eclampsia (PE), one of the major complications of pregnancy, is characterized by increased blood pressure and proteinuria 1 , and is often associated with intrauterine growth restriction (IUGR). Pre-eclampsia and/or IUGR are associated with impaired trophoblastic invasion of the maternal spiral arteries 2 . Doppler studies of the uteroplacental circulation have demonstrated that in pregnancies with impaired placentation, there is increased impedance to flow 3 . Furthermore, increased impedance to flow at 23 weeks identifies a group of patients at increased risk of subsequent development of PE and/or IUGR and especially for severe, early-onset disease 4 prior to any sign of clinical disease.
Normal pregnancy is characterized by an increase in platelet aggregation and a decrease in the number of circulating platelets with gestation [5] [6] [7] . In women with PE and/ or IUGR, there is known to be a reduction in platelet count 8, 9 . The changes in platelet function are more complex. Whereas in the early stages of PE platelet aggregation is increased, in established severe disease it is decreased 10 . Longitudinal studies suggest that increased platelet aggregation may predate the development of PE by 2-5 weeks 11 . The aim of this cross-sectional study was to compare changes in mean platelet volume (MPV), platelet count and function in women at 23 weeks of gestation undergoing Doppler ultrasound of the uterine arteries. Platelet changes were investigated in those with normal uterine artery Doppler and normal pregnancy outcome, and those with abnormal uterine artery Doppler who subsequently had normal or pathological (PE or IUGR) outcome.
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MATERIALS AND METHODS
All women attending for routine antenatal care at an inner city teaching hospital underwent routine uterine artery color Doppler examination at median 23 weeks' gestation (range 22-25 weeks) as part of the anomaly scan 4 . The right and left uterine arteries were identified at the apparent crossover with the external iliac artery using color Doppler. Pulsed-wave Doppler was used to obtain uterine artery waveforms using Acuson Aspen or Aloka SSD-1700 color Doppler apparatus (Acuson, Mountain View, CA, USA; Aloka, Tokyo, Japan). When three similar consecutive waveforms were obtained, the presence of an early diastolic notch was recorded, pulsatility index (PI) measured, and the mean PI of the two vessels calculated. Women with bilateral uterine artery notches, and / or those with raised impedance (mean PI of 1.45 or higher) constituted the abnormal uterine artery Doppler group 4 . The women in our study were prospectively allocated into abnormal and normal uterine artery groups. All women were healthy, normotensive and not taking any medication for at least 2 weeks prior to testing. None had a cardiovascular condition, specifically diabetes, hypertension or renal disease. All fetuses were appropriately grown for gestation and there was no ultrasound evidence of fetal anomaly.
Immediately after Doppler examination MPV, platelet count and in vitro platelet aggregation were examined in blood obtained from 31 women (16 primiparas, 15 multiparas) with abnormal uterine artery Doppler, 29 women (13 primiparas, 16 multiparas) with normal Doppler indices and 16 non-pregnant controls. The result of the Doppler examination was made available to the researchers performing the platelet examinations at 23 weeks. However, platelet data were concealed and only collated at the end of pregnancy.
All pregnancies were followed up for the development of PE (defined by a blood pressure of 140/90 mmHg or greater with proteinuria of at least 300 mg / 24 h or dipstick testing of 300 mg /L) 1 . Fetal growth restriction (IUGR) was defined as a birth weight below the fifth centile 12 . The study was approved by the hospital ethics committee, and informed consent was obtained from the patients and non-pregnant controls.
Twenty milliliters of blood was obtained by anticubital venepuncture without stasis and collected into a polypropylene vial containing 3.15% sodium citrate solution (v:v, 9 : 1). The platelet count and MPV in whole blood were measured immediately using a Coulter Counter (Sysmex Ltd, Buckinghamshire, UK). In vitro platelet aggregation studies were performed using platelet-rich plasma (PRP) according to the method of Born 13 . Blood was centrifuged at 200 g for 20 min within 15 min after collection and PRP was aspirated. The remainder of the sample was centrifuged at 600 g for 10 min to obtain platelet-poor plasma (PPP). Platelet count in PRPs was adjusted to 2-2.5 × 10 11 /L using autologous PPP and the PRP kept still at room temperature for 30 min. In vitro platelet aggregation was monitored using a dual-channel ChronoLog-aggregometer (Chrono-Log Corporation, Havertown, PA, USA) at 37°C with continuous stirring. The aggregometer was connected to a computer database, and the data analyzed using Aggro/ Link software (Chrono-Log Corporation). Collagen (Horm, Nycomed Arzneimittel, Munich, Germany) and adenosine 5′-diphosphate (ADP, Sigma-Aldrich, Poole, UK) in increasing concentrations (0.5, 1, 2, 4 µg /mL) and (0.5, 1, 2, 5 µm), respectively, were used as pro-aggregating agents. In vitro platelet aggregation was monitored for 6 min after addition of the respective concentration of the proaggregating agents. In vitro platelet aggregation was expressed as a percentage of the light transmission at 6 min related to the negative control (PPP).
Statistical analysis
Comparisons were made between MPV, platelet count and in vitro platelet aggregation in women screened by uterine artery Doppler with normal and abnormal uterine artery Doppler, and non-pregnant controls. Further comparisons between MPV, platelet count and in vitro platelet aggregation in women with normal uterine artery Doppler were made with those with abnormal uterine artery Doppler according to pregnancy outcome (PE or IUGR). In all cases the non-parametric Mann-Whitney U-test was used to investigate the differences between the groups using STATA version 6.0 (STATA Corporation, College Station, TX, USA).
RESULTS
The presence of abnormal uterine artery Doppler in the local population of our inner city teaching hospital was about 6% 4 . The characteristics of the normal and abnormal uterine artery Doppler groups are described in Table 1 . The study and the control groups were drawn from over 1000 women undergoing uterine artery Doppler screening over a 1-year period after individual consent. All 29 pregnancies with normal uterine artery Doppler at 22-25 weeks had a normal pregnancy outcome. In the 31 women with abnormal uterine artery Doppler at 23 weeks, eight developed PE 5-15 (median, 12) weeks after screening, of whom four also developed IUGR. Four women delivered babies with IUGR at 36 -40 (median, 40) weeks' gestation without PE. Two women had a placental abruption of which one resulted in an Table 2 and Figure 1 and values in relation to pregnancy outcome are shown in Table 3 and Figure 2 . When all the data were pooled there was a significant correlation between MPV and platelet count (r = −0.553, P < 0.0001). Two women with abnormal Doppler subsequently had placental abruption but as these were not associated with PE or IUGR we included their data in the screening statistics, but excluded them from the outcome analysis as no outcome group adequately described their pathology.
No significant differences in platelet count and in vitro platelet aggregation induced by collagen were seen between pregnant women with normal and abnormal uterine artery Doppler, and non-pregnant controls. Differences in MPV and in vitro platelet aggregation using ADP 1 µm as pro-aggregating agents were observed between the groups. This concentration of ADP was used as it identified the greatest separation between the groups; similar results were observed with 0.5 µm, whereas 2 µm resulted in near maximal aggregation.
Mean platelet volume was greater in women with abnormal uterine artery Doppler compared with those with normal Doppler (10.2 vs. 9.4 fL, P = 0.02) ( Table 2 and Figure 1) .
In vitro platelet aggregation by ADP was increased in pregnant women with normal and abnormal uterine artery Doppler compared with non-pregnant controls (37 vs. 13%, P = 0.02 and 40 vs. 13%, P = 0.03) ( Table 2 and Figure 1 ).
Mean platelet volume was significantly higher (10.3 vs. 9.4 fL, P = 0.01) in the women with abnormal uterine artery Non-pregnant n = 16; normal Doppler n = 29; abnormal Doppler n = 31. *P = 0.02 compared with normal uterine artery Doppler. †P = 0.02 compared to non-pregnant controls, ‡P = 0.03 compared with non-pregnant controls. (Table 3 and Figure 2 ). In vitro platelet aggregation with ADP was lower in those with abnormal uterine artery Doppler and normal pregnancy outcome compared with women with normal uterine artery Doppler, but this was of borderline significance (21 vs. 37%, P = 0.08). Eight women with abnormal uterine artery Doppler who subsequently developed PE had similar platelet number, volume and aggregation to both collagen and ADP, whether or not IUGR was present (four in each group). We considered these women as pre-eclamptic.
In the group with abnormal uterine artery Doppler, the women who developed PE had normal MPV but significantly higher ADP-induced in vitro platelet aggregation than those with normal outcome (66.5 vs. 21%, P = 0.02).
In women with abnormal uterine artery Doppler who delivered IUGR infants compared with those with abnormal Doppler but normally grown infants, MPV did not differ but ADP-induced in vitro platelet aggregation was higher (66.5 vs. 21%, P = 0.03) (Figure 2 and Table 3) .
We observed the highest MPV in women with abnormal uterine artery blood flow and either normally grown or IUGR infants. ADP-induced in vitro platelet aggregation was highest in those with abnormal uterine artery Doppler and subsequent development of PE and/or IUGR (Table 3 and Figure 2 ).
DISCUSSION
In agreement with a previous study 5 , we were unable to demonstrate a significant change in platelet count and MPV at 23 weeks' gestation in normal pregnancy compared with non-pregnant controls. However, we did observe a significant increase in platelet aggregation induced by ADP. As found in our previous study, MPV in women with abnormal uterine artery Doppler was increased in comparison with women with normal uterine artery Doppler 14 . The difference in the absolute measured MPV between the studies is most likely related to the different method used by Lees et al. 14 , as they centrifuged the blood at 190 g for 20 min and measured MPV in PRP, which is known to affect their MPVs 15 . In this study, the data suggest that in women with abnormal uterine artery Doppler, MPV and platelet function are altered with specific patterns of change associated with subsequent adverse pregnancy outcome. Impaired placentation and increased impedance to flow may cause endothelial changes due to increased shear stress or alterations in circulating platelets 16, 17 . We used two pro-aggregating reagents to assess in vitro platelet function and demonstrated differences in the response of platelets in the various subgroups to these reagents. Collagen causes direct mechanical rupture and aggregation of the platelets, and no significant difference could be observed between the normal and abnormal groups with maximum in vitro aggregation achieved in both. Using ADP, the in vitro aggregation in the normal outcome groups was about 30%, whereas in those that subsequently developed PE or IUGR, aggregation was twice as high. Because the effects of ADP on platelets are membrane-receptor-mediated 18 , our results suggest changes in the membrane receptors and/or changes in the intracellular response of platelets in women with abnormal pregnancy outcome.
In the group with abnormal Doppler, those that subsequently developed IUGR had increased MPV and ADPinduced in vitro platelet aggregation. In this group there may be increased consumption of platelets in the uteroplacental circulation leading to a reduction in the number of circulating platelets, and a compensatory increase in bone marrow platelet production. Platelet consumption results in the physiological release of younger platelets which are known to have a higher MPV and aggregation tendency 19, 20 . It has been suggested that platelet consumption might be confined to the uteroplacental circulation causing IUGR but no other pathological maternal sequelae 21 . In contrast, in the group with abnormal Doppler but normal fetal growth, MPV was increased but ADP-induced in vitro platelet aggregation was normal. In this group platelet consumption and destruction may occur systemically rather than in the uteroplacental circulation, hence are not associated with increased aggregation and are not leading to significant uteroplacental insufficiency and IUGR.
In the group with abnormal uterine artery Doppler that subsequently developed PE, there was normal platelet count and MPV but increased ADP-induced in vitro platelet aggregation. This alteration in platelet function may be an early response predating changes in MPV which have been shown to increase 2-5 weeks before the onset of clinical disease 11, 22 . 
